Evidence map›Paper›PMID 35986493›Full record

ArticleJournal of pineal research2022

Melatonin drives apoptosis in head and neck cancer by increasing mitochondrial ROS generated via reverse electron transport.

Javier Florido, Laura Martinez-Ruiz, César Rodriguez-Santana, Alba López-Rodríguez, Agustín Hidalgo-Gutiérrez, Cécile Cottet-Rousselle, Frédéric Lamarche, Uwe Schlattner, Ana Guerra-Librero, Paula Aranda-Martínez and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of pineal research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 80 citations in OpenAlex.

  1. Melatonin exerts anOncology letters · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. An engineered mitoCBE facilitates efficient mitochondrial DNA editing and modified mitochondrial transfer.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Javier FloridoInstitute of Biotechnology, Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain.
Laura Martinez-RuizInstitute of Biotechnology, Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain.
César Rodriguez-SantanaInstitute of Biotechnology, Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain.
Alba López-RodríguezInstitute of Biotechnology, Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain.
Agustín Hidalgo-GutiérrezInstitute of Biotechnology, Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain.
Cécile Cottet-RousselleINSERM U1055, Laboratory of Fundamental and Applied Bioenergetics (LBFA), University of Grenoble Alpes, Grenoble, France.
Frédéric LamarcheINSERM U1055, Laboratory of Fundamental and Applied Bioenergetics (LBFA), University of Grenoble Alpes, Grenoble, France.
Uwe SchlattnerINSERM U1055, Laboratory of Fundamental and Applied Bioenergetics (LBFA), University of Grenoble Alpes, Grenoble, France.
Ana Guerra-LibreroInstitute of Biotechnology, Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain.
Paula Aranda-MartínezInstitute of Biotechnology, Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain.
Darío Acuña-CastroviejoInstitute of Biotechnology, Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain.ORCID http://orcid.org/0000-0002-9680-1560
Luis C LópezInstitute of Biotechnology, Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain.
Germaine EscamesInstitute of Biotechnology, Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain.ORCID http://orcid.org/0000-0003-1256-7656
Universidad de Granada · ESInserm · FR

Funding

Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (P18-RT-32222)European Regional Development Fund (B-CTS-071-UGR18)Funding for open access charge: CBUA/Universidad de GranadaMinisterio de Ciencia e Innovación/AEI: Agencia Estatal de Investigación/10.13039/501100011033/Financiado por la Unión Europea "NextGenerationEU"/PRTR (SAF2017-85903-P; PID2020-115112RB-I00)Ministerio de Educación, Cultura y Deporte (ayuda para contratos Predoctorales: FPU16/05304; FPU17/01549)
6 · The paper itself

Abstract

The oncostatic effects of melatonin correlate with increased reactive oxygen species (ROS) levels, but how melatonin induces this ROS generation is unknown. In the present study, we aimed to elucidate the two seemingly opposing actions of melatonin regarding its relationship with free radicals. We analyzed the effects of melatonin on head and neck squamous cell carcinoma cell lines (Cal-27 and SCC-9), which were treated with 0.5 or 1 mM melatonin. We further examined the potential effects of melatonin to induce ROS and apoptosis in Cal-27 xenograft mice. Here we report that melatonin mediates apoptosis in head and neck cancer by driving mitochondrial reverse electron transport (RET) to induce ROS production. Melatonin-induced changes in tumoral metabolism led to increased mitochondrial activity, which, in turn, induced ROS-dependent mitochondrial uncoupling. Interestingly, mitochondrial complex inhibitors, including rotenone, abolished the ROS elevation indicating that melatonin increased ROS generation via RET. Melatonin also increased membrane potential and CoQ

Indexed as

Head and Neck NeoplasmsMelatoninAnimalsApoptosisElectron TransportHumansMiceReactive Oxygen SpeciesMelatoninReactive Oxygen Speciesapoptosishead and neck cancer cellsmelatoninmitochondriaoxidative damagereactive oxygen speciesreverse electron transport

Identifiers

PMID35986493
PMCPMC9541246
OpenAlexW4292495385

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.